Viscoelastic haemostatic assays to guide therapy in elective surgery: an updated systematic review and meta‐analysis
Anaesthesia · 2025-01 · 80 (1) · 95-103
DOI: 10.1111/anae.16463 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Anaesthesia, online erschienen am 14.11.2024. Verfasst von Joao D Dias und 4 weiteren Autor:innen. Beteiligte Einrichtung: Haemonetics SA, Signy, Switzerland. Hauptthemen laut MEDLINE: Elective Surgical Procedures, Thrombelastography. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Haemonetics, Haemonetics Corporation.
Abstract (Originalsprache)
Background
Patients undergoing major surgery frequently experience major uncontrolled bleeding. The aim of this systematic review and meta‐analysis was to evaluate the clinical efficacy of using viscoelastic haemostatic assays to manage peri‐operative bleeding in elective surgery.
Methods
We searched PubMed/MEDLINE and Embase databases for randomised controlled trials according to pre‐determined criteria. The primary outcomes were blood product requirements; duration of stay in the operating theatre or ICU; and surgical reintervention rate.
Results
We included 20 randomised controlled trials. The overall risk of bias was low to moderate. Twelve studies used thromboelastography‐based transfusion algorithms, while eight used thromboelastometry. Viscoelastic haemostatic assay‐guided therapy was associated with a statistically significant reduction in transfusion of red blood cells (standardised mean difference (95%CI) 0.16 (‐0.29 to 0.02)), platelets (standardised mean difference (95%CI) ‐0.33 (‐0.56 to ‐0.10)) and fresh frozen plasma (standardised mean difference (95%CI) ‐0.64 (‐1.01 to ‐0.28)). There was no evidence of an effect of viscoelastic haemostatic assay‐guided therapy on surgical reintervention (relative risk (95%CI) 1.09 (0.70–1.69)). Viscoelastic haemostatic assay‐guided therapy was associated with lower blood loss and shorter ICU duration of stay. There was no evidence of any effect on total duration of stay and all‐cause mortality.
Conclusions
Viscoelastic haemostatic assay‐guided therapy may reduce peri‐operative blood product transfusion requirements and blood loss during major elective surgery, with no discernible effect on patient‐centred outcomes. The overall quality of evidence was modest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Haemonetics SA, Signy, Switzerland.
- Departments of Anesthesiology, Critical Care and Surgery, Duke University School of Medicine, Durham, NC, USA.
- Department of Anesthesiology, University of Oklahoma, Health Sciences Center, Oklahoma City, OK, USA.
- Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
- Haemonetics Corp, Boston, MA, USA.
Förderung
- Haemonetics
- Haemonetics Corporation
Zitieren
APA
Dias, J. D., Levy, J. H., Tanaka, K. A., Zacharowski, K., & Hartmann, J. (2025). Viscoelastic haemostatic assays to guide therapy in elective surgery: an updated systematic review and meta‐analysis. Anaesthesia, 80(1), 95-103. https://doi.org/10.1111/anae.16463
Vancouver
Dias JD, Levy JH, Tanaka KA, Zacharowski K, Hartmann J. Viscoelastic haemostatic assays to guide therapy in elective surgery: an updated systematic review and meta‐analysis. Anaesthesia. 2025;80(1):95-103. doi:10.1111/anae.16463
BibTeX
@article{Dias2025,
author = {Dias, Joao D and Levy, Jerrold H and Tanaka, Kenichi A and Zacharowski, Kai and Hartmann, Jan},
title = {Viscoelastic haemostatic assays to guide therapy in elective surgery: an updated systematic review and meta‐analysis},
journal = {Anaesthesia},
year = {2025},
volume = {80},
number = {1},
pages = {95--103},
doi = {10.1111/anae.16463}
}
EUVIMED